WORLDWIDE, CERVICAL CANCER IS THE FOURTH MOST COMMON CANCER AMONG WOMEN AND A MAJOR CAUSE OF CANCER-RELATED DEATHS¹

Screening efficiency is proven and pre-cancers can be treated².
DATEXIM solutions raise diagnostic accuracy to a level never reached before,
reducing risks of missed cases and helping to save women’s lives.

¹ ² Sources

¹Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 2020; ARTICLES| VOLUME 8, ISSUE 2, PE191-E203, FEBRUARY 01, 2020. Published Online December 4, 2019 Link
www.thelancet.comPDF Version

²www.who.int

. In 2020 ² .
0
new cases in the world
0
deaths
+
0
%
between 2000 & 2020

.Our solution.

Our unique and innovative solution to revolutionize cervical cancer diagnostics

DATEXIM revolutionizes cervical cancer screening thanks to the first Artificial Intelligence CE marked solution.

.CytoProcessor® Cases.
CYTOPROCESSOR -Case n°3
.Webinar.
Webinar : digital cytology and AI
.News.